News
Aspire Biopharma Holdings, Inc, a developer of a multi-faceted patent-pending drug delivery technology, announced initiation of its phase 1 single-centre clinical study of its lead therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback